In vitro circulation model driven by tissue-engineered dome-shaped cardiac tissue
Source abstract
Abstract
Abstract The heart is an essential organ for animals and humans. With the increased availability of pluripotent stem cells, the use of three-dimensional cardiac tissues consisting of cultured cardiomyocytes in in vitro drug evaluation has been widely studied. Several models have been proposed for the realization of the pump function, which is the original function of the heart. However, there are no models that simulate the human circulatory system using cultured cardiac tissue. This study shows that a dome-shaped cardiac tissue fabricated using the cell sheet stacking technique can achieve a heart-like pump function and circulate culture medium, there by mimicking the human circulatory system. Firstly, human induced pluripotent stem cells were differentiated into autonomously beating cardiomyocytes, and cardiomyocyte cell sheets were created using temperature-responsive culture dishes. A cardiomyocyte sheet and a human dermal fibroblast sheet were stacked using a cell sheet manipulator. This two-layered cell sheet was then inflated to create a dome-shaped cardiac tissue with a base diameter of 8 mm. The volume of the dome-shaped cardiac tissue changed according to the autonomous beating. The stroke volume increased with the culture period and reached 21 ± 8.9 μ l ( n = 6) on day 21. It also responded to β -stimulant and extracellular calcium concentrations. Internal pressure fluctuations were also recorded under isovolumetric conditions by dedicated culture devices. The peak heights of pulsatile pressure were 0.33 ± 0.048 mmHg ( n = 3) under a basal pressure of 0.5 mmHg on day 19. When the tissue was connected to a flow path that had check valves applied, it drove a directional flow with an average flow rate of approximately 1 μ l s −1 . Furthermore, pressure–volume ( P – V ) diagrams were created from the simultaneous measurement of changes in pressure and volume under three conditions of fluidic resistance. In conclusion, this cardiac model can potentially be used for biological pumps that drive multi-organ chips and for more accurate in vitro drug evaluation using P – V diagrams.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes10.1016/j.vascn.2016.12.003 ↗
2. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study10.1254/jphs.13248FP ↗
3. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes10.1016/j.vascn.2015.04.002 ↗
4. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes10.1016/j.scr.2009.11.004 ↗
5. Bridging functional and structural cardiotoxicity assays using human embryonic stem cell-derived cardiomyocytes for a more comprehensive risk assessment10.1093/toxsci/kfv180 ↗
6. Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays10.1093/toxsci/kft113 ↗
7. Proarrhythmia risk assessment in human induced pluripotent stem cell-derived cardiomyocytes using the maestro MEA platform10.1093/toxsci/kfv128 ↗
8. Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development10.1186/scrt375 ↗
9. Organ/body-on-a-chip based on microfluidic technology for drug discovery10.1016/j.dmpk.2017.11.003 ↗
10. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X ↗
11. Liver–Heart on chip models for drug safety10.1063/5.0048986 ↗
12. Organ system crosstalk in cardiometabolic disease in the age of multimorbidity10.3389/fcvm.2020.00064 ↗
13. Tissue engineering10.1126/science.8493529 ↗
14. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system10.1096/fasebj.11.8.9240969 ↗
15. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes10.1002/(SICI)1097-0290(20000405)68:1<106::AID-BIT13>3.0.CO;2-3 ↗
16. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?10.1161/circ.102.suppl_3.III-56 ↗
17. Construction of a bioengineered cardiac graft10.1016/S0022-5223(00)70193-0 ↗
18. Tissue engineering of a differentiated cardiac muscle construct10.1161/hh0202.103644 ↗
19. Development of a drug screening platform based on engineered heart tissue10.1161/CIRCRESAHA.109.211458 ↗
20. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes10.1038/nmeth.2524 ↗
21. Automated analysis of contractile force and Ca2+ transients in engineered heart tissue10.1152/ajpheart.00705.2013 ↗
22. Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue10.1371/journal.pone.0198026 ↗
23. Miniaturized iPS-cell-derived cardiac muscles for physiologically relevant drug response analyses10.1038/srep24726 ↗
24. Engineered cardiac organoid chambers: toward a functional biological model ventricle10.1089/tea.2007.0351 ↗
25. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells10.1016/j.biomaterials.2018.02.024 ↗
26. Human cardiac ventricular-like organoid chambers and tissue strips from pluripotent stem cells as a two-tiered assay for inotropic responses10.1002/cpt.1385 ↗
27. Pulsatile tubular cardiac tissues fabricated by wrapping human iPS cells-derived cardiomyocyte sheets10.1016/j.reth.2019.09.001 ↗
28. 3D bioprinting of collagen to rebuild components of the human heart10.1126/science.aav9051 ↗
29. Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer10.1038/s41598-020-65681-y ↗
30. Gold nanocomposite bioink for printing 3D cardiac constructs10.1002/adfm.201605352 ↗
31. 3D bioprinted functional and contractile cardiac tissue constructs10.1016/j.actbio.2018.02.007 ↗
32. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels10.1126/sciadv.aaw2459 ↗
33. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels10.1038/ncomms2406 ↗
34. In vitro engineering of vascularized tissue surrogates10.1038/srep01316 ↗
35. Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis10.1038/nmat4570 ↗
36. 3D printing of personalized thick and perfusable cardiac patches and hearts10.1002/advs.201900344 ↗
37. Hemodynamic stimulation using the biomimetic cardiac tissue model (BCTM) enhances maturation of human induced pluripotent stem cell-derived cardiomyocytes10.1159/000496934 ↗
38. An actuated pump on-chip powered by cultured cardiomyocytes10.1039/b515149j ↗
39. A micro-spherical heart pump powered by cultured cardiomyocytes10.1039/B612082B ↗
40. An ultra-small fluid oscillation unit for pumping driven by self-organized three-dimensional bridging of pulsatile cardiomyocytes on elastic micro-piers10.1016/j.snb.2019.04.087 ↗
41. Induction of pluripotent stem cells from adult human fibroblasts by defined factors10.1016/j.cell.2007.11.019 ↗
42. Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro10.1038/nprot.2012.027 ↗
43. Measuring the density and viscosity of culture media for optimized computational fluid dynamics analysis of in vitro devices10.1016/j.jmbbm.2021.105024 ↗
44. Biofabrication of natural hydrogels for cardiac, neural, and bone tissue engineering applications10.1016/j.bioactmat.2021.03.040 ↗
45. Construction of 3D cardiac tissue with synchronous powerful beating using human cardiomyocytes from human iPS cells prepared by a convenient differentiation method10.1016/j.jbiosc.2020.01.001 ↗
46. Micro pumping with cardiomyocyte–polymer hybrid10.1039/b703900j ↗
47. Fabrication of mouse embryonic stem cell-derived layered cardiac cell sheets using a bioreactor culture system10.1371/journal.pone.0052176 ↗
48. Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues10.1038/srep42290 ↗
49. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease10.1016/j.stem.2020.05.004 ↗
50. Cardiac fi broblast-derived VCAM-1 enhances cardiomyocyte proliferation for fabrication of bioengineered cardiac tissue10.1016/j.reth.2016.01.005 ↗
51. Cardiac tissue chips (CTCs) for modeling cardiovascular disease10.1109/TBME.2019.2905763 ↗